Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Industry Growth Insights: Revenue Forecast to 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the artificial intelligence (ai)-powered clinical trial site feasibility market from 2026–2035 with trusted insights from The Business Research Company
What are the forecasted starting (2026) and ending (2030) market sizes for the Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?
The artificial intelligence (AI)-powered clinical trial site feasibility market size has observed significant growth in recent years. It is anticipated to expand from $1.53 billion in 2025 to $1.89 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.6%. This historic expansion can be attributed to several factors, including the increasing complexity of clinical trial designs, rising cost pressures on drug development timelines, a growing reliance on data-driven trial planning, the expansion of global multi-site clinical trials, and the early adoption of predictive analytics in trial feasibility.
The artificial intelligence (AI)-powered clinical trial site feasibility market is poised for significant expansion in the coming years. It is projected to reach $4.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 23.3%.
The anticipated market increase during this period is largely driven by factors such as the increasing adoption of decentralized clinical trials, a rising need for quicker site activation, the growing application of real-world evidence in feasibility decisions, the expansion of AI-enabled trial planning platforms, and a heightened emphasis on mitigating trial risks.
Key developments expected throughout the forecast timeframe include the increasing adoption of AI-driven site selection models, a growing utilization of predictive patient recruitment analytics, the deepening integration of real-world data in feasibility assessment, the expansion of cloud-based feasibility platforms, and an enhanced focus on forecasting trial performance.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28137&type=smp
What Drivers Are Supporting Technological Adoption In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?
The expansion of clinical trials is anticipated to drive the growth of the artificial intelligence (AI)-powered clinical trial site feasibility market going forward. Clinical trials are global research endeavors undertaken to evaluate the safety and effectiveness of new medical treatments, drugs, and devices. The increasing volume of these trials is primarily fueled by greater investment in biomedical research and development, as both government and private sectors acknowledge the critical need for innovative therapies to address evolving healthcare challenges. This proliferation of clinical trials generates a demand for AI-powered site feasibility tools because research organizations require efficient systems to identify optimal locations, assess site capabilities, and predict enrollment success rates for their studies. For example, in April 2025, the Multidisciplinary Digital Publishing Institute, a Switzerland-based publisher of open-access scientific journals, reported that the total number of interventional clinical trials, hereafter referred to as clinical trials, listed on the clinicaltrials.gov webpage was 404,637. Consequently, the rising number of clinical trials is a significant factor propelling the growth of the artificial intelligence (AI)-powered clinical trial site feasibility market.
What Segment Types Are Examined In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?
The artificial intelligence (AI)-powered clinical trial site feasibility market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Site Selection, Patient Recruitment, Protocol Design, Performance Analytics, Other Applications
4) By End-User: Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes, Hospitals, Other End-Users
Subsegments:
1) By Software: Predictive Analytics Software, Machine Learning (ML) Platforms, Natural Language Processing (NLP) Tools, Data Visualization Software, Clinical Trial Management System (CTMS) Integration Software, Real-World Data (RWD) Analytics Software, Risk-Based Monitoring (RBM) Software
2) By Services: Feasibility Assessment Services, Site Selection Services, Patient Recruitment Support Services, Data Management And Analytics Services, Protocol Optimization Services, Regulatory Compliance Support Services, Consulting And Advisory Services
Which Trends Are Shaping Activity Within The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?
Leading companies within the artificial intelligence-powered clinical trial site feasibility market are concentrating their efforts on creating sophisticated solutions, exemplified by an artificial intelligence-powered feasibility and recruitment platform. These platforms aim to streamline the selection of trial sites and elevate the overall operational effectiveness of clinical trials. An artificial intelligence-powered feasibility and recruitment platform represents a software innovation that utilizes AI and machine learning capabilities to evaluate trial protocols and site-specific information. Its core function is to pinpoint the most suitable clinical sites and improve patient enrollment by effectively pairing qualified individuals, thereby expediting trial schedules and increasing the likelihood of study success. A notable illustration occurred in June 2023, when ObjectiveHealth, an integrated research and technology platform company based in the US, introduced ObjectiveScreen. This specific artificial intelligence-powered feasibility and recruitment platform was engineered to refine clinical trial performance through improved patient identification, prequalification processes, and retention rates, achieved via real-time integration with electronic health records (EHRs) and the application of AI and machine learning algorithms. The system further empowers clinical trial sites to directly access patient data, categorize health risks, and discern the most suitable candidates, ultimately accelerating participant enrollment and yielding better trial results.
Who Are The Top-Performing Companies In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In Recent Years?
Major companies operating in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systèmes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market?
North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28137&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market 2026, By The Business Research Company
Virtual Clinical Trials Market Report 2026
https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report
Ai Based Clinical Trial Solution Providers Market Report 2026
Ai In Clinical Trials Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
